DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-8.13%
US · US
ETR.US latest organized financial period shows revenue grew +8.98% YoY and net income lacks a complete YoY comparison. Current price is about 117 USD, while the model base case is about 117 USD; the current price sits +0.3% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:27
Hover each model row to inspect formulas and inputs.
+0.27%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-8.13%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+32.1%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -3.1% annualized FCF growth.
Estimates earnings power value without assuming growth.
+0.27%
Updated: 2026/04/29 15:27
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -10M USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -169M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -101M USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -387M USD | Medium |
| 2022/12/31 | Restructuring charges | Restructuring | -5M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -625M USD | Medium |
| 2021/12/31 | Restructuring charges | Restructuring | -10M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -63M USD | Medium |
| 2025/09/30 | Asset impairment | Impairment | -20M USD | Medium |
| 2024/09/30 | Asset impairment | Impairment | -208M USD | Medium |
| 2024/06/30 | Asset impairment | Impairment | -208M USD | Medium |
| 2024/03/31 | Asset impairment | Impairment | -208M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 13B USD | - | - | -3B USD | 3.91 | 3.96 |
| 2024/12/31 | Annual | 12B USD | - | - | -350M USD | 2.45 | 3.25 |
| 2023/12/31 | Annual | 12B USD | 2B USD | 2B USD | -146M USD | 11.1 | 11.58 |
| 2022/12/31 | Annual | 14B USD | 1B USD | 1B USD | -2B USD | 5.37 | 7.28 |
| 2021/12/31 | Annual | - | 1B USD | 2B USD | 2B USD | 5.54 | 8.69 |
Operating cash flow after capital expenditures.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.